Stock listing

FATE Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: FATE · BOATS · USD · US

FATE:BOATS is the ticker for Fate Therapeutics, Inc., a public biotechnology company based in the United States. The company specializes in developing cellular immunotherapies aimed at treating cancer and immune disorders. With a market capitalization of around $280.9 million, Fate Therapeutics is committed to advancing its innovative therapies through ongoing research and development in regenerative medicine. Recent news and filings may provide insights into the company's progress and future initiatives.

FATE:BOATSUSDUSUpdated July 24, 2026
Fate Therapeutics, Inc. logo
Ticker
FATE:BOATS
Asset type
Stock
Market cap
$280.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Fate Therapeutics, Inc. FATE:BOATS stock context

FATE:BOATS is the ticker for Fate Therapeutics, Inc., a public biotechnology company based in the United States. The company specializes in developing cellular immunotherapies aimed at treating cancer and immune disorders. With a market capitalization of around $280.9 million, Fate Therapeutics is committed to advancing its innovative therapies through ongoing research and development in regenerative medicine. Recent news and filings may provide insights into the company's progress and future initiatives.

Research Fate Therapeutics, Inc.

Alternate listings